A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruptio

A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruptio

Online publication: 16/04/2020 Journal: PNAS

Abstract:

HIV-1 persists in cellular reservoirs that can reignite viremia if antiretroviral therapy (ART) is interrupted. Therefore, insight into the nature of those reservoirs may be revealed from the composition of recrudescing viremia following treatment cessation. A minor population of macrophage-tropic (M-tropic) viruses was identified in a library of recombinant viruses constructed with individual envelope genes that were obtained from plasma of six individuals undergoing analytic treatment interruption (ATI). M-tropic viruses could also be enriched from post-ATI plasma using macrophage-specific (CD14) but not CD4+ T cell-specific (CD3) antibodies, suggesting that M-tropic viruses had a macrophage origin. Molecular clock analysis indicated that the establishment of M-tropic HIV-1 variants predated ATI. Collectively, these data suggest that macrophages are a viral reservoir in HIV-1–infected individuals on effective ART and that M-tropic variants can appear in rebounding viremia when treatment is interrupted. These findings have implications for the design of curative strategies for HIV-1.

Authors: Viviane M. Andrade, Carla Mavian, Dunja Babic, Thaissa Cordeiro, Mark Sharkey, Labelle Barrios, Christian Brander, Javier Martinez-Picado, Judith Dalmau, Anuska Llano, Jonathan Z. Li, Jeffrey Jacobson, Christy L. Lavine, Michael S. Seaman, Marco Salemi, and Mario Stevenson

Subscribe to our newsletter

Back to Top
Irsi Caixa

Promoted by:

'La Caixa' Foundation Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Member of:

Cerca

In cooperation with: